| 12161716 |
Anti-IL-23 antibodies, compositions, methods and uses |
Jacquelne Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2024-12-10 |
$399,151,000 |
| 12129293 |
Medical device for administering anti-IL-23 antibodies |
Jacqueline Benson, Jill Carton, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet |
2024-10-29 |
$304,380,000 |
| 11185584 |
Anti-IL-23 antibodies, compositions, methods and uses |
Jacqueline Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2021-11-30 |
$200,682,000 |
| 10954297 |
Methods of treatment using human anti-IL-23 antibodies |
Jacqueline Benson, Jill Carton, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet |
2021-03-23 |
$120,756,000 |
| 10576150 |
Anti-IL-23 antibodies |
Jacqueline Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2020-03-03 |
$89,998,000 |
| 10272152 |
Anti-IL-23 antibodies, compositions, methods and uses |
Jacqueline Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2019-04-30 |
$125,033,000 |
| 10128791 |
Structures and methods for supporting solar panels |
Thomas Ludwig, Gaelen Clark McKee |
2018-11-13 |
|
| 10030070 |
Human anti-IL-23 antibodies, compositions, methods and uses |
Jacqueline Benson, Jill Carton, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet |
2018-07-24 |
$137,624,000 |
| 9932404 |
Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist |
Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger, Mark Rutz +6 more |
2018-04-03 |
$144,907,000 |
| 9783607 |
Human anti-IL-23 antibodies, compositions, methods and uses |
Jacqueline Benson, Jill Carton, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet |
2017-10-10 |
$90,238,000 |
| 9714287 |
Anti-IL-23 antibody compositions |
Jacqueline Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2017-07-25 |
$95,050,000 |
| 9522957 |
Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists |
Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger, Mark Rutz +6 more |
2016-12-20 |
$111,824,000 |
| 9505837 |
Anti-IL-23 antibodies |
Jacqueline Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2016-11-29 |
$116,366,000 |
| 9481731 |
Toll-like receptor 3 antagonists |
Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger, Mark Rutz +7 more |
2016-11-01 |
$111,174,000 |
| 9353181 |
Human anti-IL-23 antibodies, compositions, methods and uses |
Jacqueline Benson, Jill Carton, Yevgeniya I. Orlovsky, Robert Rauchenberger, Raymond Sweet |
2016-05-31 |
$72,477,000 |
| 9255153 |
Polynucleotides encoding Toll-Like Receptor 3 antagonists |
Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger, Mark Rutz +6 more |
2016-02-09 |
$105,679,000 |
| 9238693 |
Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies |
Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger, Mark Rutz +6 more |
2016-01-19 |
$69,176,000 |
| 9127058 |
Anti-IL-23 Antibodies |
Jacqueline Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2015-09-08 |
$45,694,000 |
| 9096667 |
Anti-IL-23 antibodies, compositions, methods and uses |
Jacqueline Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2015-08-04 |
$64,594,000 |
| 8835445 |
Dihydrofolate reductase inhibitors |
Zhiyong Chen, Christopher J. Creighton, John Finn, Mark Hilgers, Michael E. Jung +7 more |
2014-09-16 |
|
| 8618264 |
Anti-CD147 antibodies, methods and uses |
Bethany Swencki-Underwood, Yi Tang, Li Yan |
2013-12-31 |
|
| 8574579 |
Anti-IL-23 antibodies |
Jacqueline Benson, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn +1 more |
2013-11-05 |
$41,776,000 |
| 8540986 |
Toll-like receptor 3 antagonists |
Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger, Mark Rutz +6 more |
2013-09-24 |
$37,122,000 |
| 8460659 |
Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases |
Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger, Mark Rutz +8 more |
2013-06-11 |
$34,348,000 |
| 8409567 |
Toll-like receptor 3 antagonists |
Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger, Mark Rutz +6 more |
2013-04-02 |
$85,775,000 |
